In the wake of at least four deaths tied to gluteal augmentation procedures, Brazil's Federal Council of Medicine has drawn a firm line between the pursuit of beauty and the preservation of life, banning the synthetic filler PMMA from all cosmetic and reconstructive use nationwide. The prohibition, effective Tuesday, reflects a reckoning that accumulated slowly — one hospitalization, one bathroom floor, one collapsed patient — until the pattern could no longer be ignored. A narrow exception survives for HIV-related lipodystrophy treatment in accredited public health units, a concession to medi
CNN Brasil
· May 29, 2026
· health
· 1 min de leitura
High
Apuração: Verificado
Brazil bans PMMA for cosmetic procedures after deaths from gluteal fillers
At least four women died from PMMA cosmetic procedures between 2024-2025, with complications including severe pain, organ failure, and death occurring hours to days after treatment.
◉
Health & Medicine
2746 artigos relacionados
Ozempic and GLP-1 drugs: how the weight-loss revolution works and what…
O GLOBO · 99% correspondência
Eli Lilly's retatrutida shows 28% weight loss in trials, rivaling bari…
Poder360 · 90% correspondência
GLP-1 drugs like Ozempic expand beyond weight loss into Alzheimer's, h…
Folha de S.Paulo · 90% correspondência
Retatrutida achieves 30% weight loss in landmark obesity study
Veja Saúde · 90% correspondência
Anvisa aprova remdesivir contra covid-19 e registra vacina de Oxford
Jornal de Brasília · 90% correspondência
Cobertura Relacionada
G1 · Aug 20
Pai agradece médicos após morte de gêmeas unidas pela cabeça: 'mais vitórias que derrotas'
Pai das gêmeas unidas pela cabeça que morreram em cirurgia de separação agradece empenho de mais de 50 profissionais do …
Folha de S.Paulo · Aug 20 Selton Mello se emociona ao receber Kikito de Cristal em GramadoSelton Mello recebeu o Kikito de Cristal no Festival de Gramado e se emocionou ao lembrar que era a primeira vez receben…
G1 · Aug 20 CEMEI Amiguinhos da Vila inaugura prédio moderno com capacidade para 320 alunosInaugurado novo prédio do CEMEI Amiguinhos da Vila em Montes Claros, com capacidade para 320 alunos, oito salas de aula,…
Folha de S.Paulo · Aug 20 Hepatites D e E circulam no Brasil e preocupam especialistasRevisão de 200 estudos com dados de 14,5 milhões de pessoas revela que hepatites D e E circulam no Brasil com prevalênci…
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
🌎
Brazil's medical council bans PMMA for cosmetic procedures nationwide following deaths, with limited geopolitical relevance but potential implications for medical tourism and regulatory harmonization.
Escalation Risk
low
Confidence
MED
Brazil
Latin America
Global cosmetic surgery market
Strengthens Brazilian regulatory autonomy in healthcare standards; may influence other Latin American nations to adopt similar restrictions; reduces competitive advantage of Brazilian cosmetic tourism sector; shifts market dynamics toward alternative fillers and procedures.
Similar to EU's 2013 ban on certain cosmetic substances following safety concerns—demonstrates how health crises drive regulatory tightening and can fragment global medical markets along regional lines.
Lente Econômica
📈
Brazil's medical council bans PMMA for cosmetic procedures nationwide following deaths from gluteal fillers, with limited exception for HIV/AIDS treatment, impacting aesthetic medicine sector.
Market Signal
bearish
Confidence
HIGH
Cosmetic and aesthetic medicine
Medical device manufacturing
Pharmaceutical/injectable products
Private healthcare clinics
Medical tourism
Consumers seeking gluteal augmentation must now pursue alternative procedures or travel abroad, increasing costs and health risks. Existing PMMA inventory becomes worthless. Patients may shift to other filler materials, potentially increasing demand for alternative products.
Regulatory precedent for banning unsafe cosmetic substances; likely increased oversight of injectable materials and practitioner licensing. May prompt similar restrictions in other Latin American countries. Potential liability litigation against manufacturers and practitioners.